Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart G Beattie

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Human Gene Therapy|May 8, 2009
Effect of adeno-associated virus serotype and genomic structure on liver transduction and biodistribution in mice of both gendersAstrid Pañeda, Lucia Vanrell, Itsaso Mauleon, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 30, 2010
Sustained enzymatic correction by rAAV-mediated liver gene therapy protects against induced motor neuropathy in acute porphyria miceCarmen Unzu, Ana Sampedro, Itsaso Mauleón, et al.
Human Gene Therapy|September 28, 2013
Safety and liver transduction efficacy of rAAV5-cohPBGD in nonhuman primates: a potential therapy for acute intermittent porphyriaAstrid Pañeda, Esperanza Lopez-Franco, Christine Kaeppel, et al.
The New England Journal of Medicine|May 5, 2015
Long-term effect of gene therapy on Leber's congenital amaurosisJames W B Bainbridge, Manjit S Mehat, Venki Sundaram, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Human Gene Therapy|May 8, 2009
Effect of adeno-associated virus serotype and genomic structure on liver transduction and biodistribution in mice of both gendersAstrid Pañeda, Lucia Vanrell, Itsaso Mauleon, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 30, 2010
Sustained enzymatic correction by rAAV-mediated liver gene therapy protects against induced motor neuropathy in acute porphyria miceCarmen Unzu, Ana Sampedro, Itsaso Mauleón, et al.
Human Gene Therapy|September 28, 2013
Safety and liver transduction efficacy of rAAV5-cohPBGD in nonhuman primates: a potential therapy for acute intermittent porphyriaAstrid Pañeda, Esperanza Lopez-Franco, Christine Kaeppel, et al.
The New England Journal of Medicine|May 5, 2015
Long-term effect of gene therapy on Leber's congenital amaurosisJames W B Bainbridge, Manjit S Mehat, Venki Sundaram, et al.
Pageof 2